Actively Recruiting
UPLYFT For Lymphoma Survivors
Led by Dana-Farber Cancer Institute · Updated on 2026-02-24
74
Participants Needed
1
Research Sites
237 weeks
Total Duration
On this page
Sponsors
D
Dana-Farber Cancer Institute
Lead Sponsor
A
American Society of Hematology
Collaborating Sponsor
AI-Summary
What this Trial Is About
The main purpose of this study is to field test and pilot an intervention called UPLYFT (Understand and Prevail: Lymphoma Fear of Recurrence Therapy) that includes information about lymphoma survivorship and tools to improve quality of life and reduce lymphoma-related worries among lymphoma survivors.
CONDITIONS
Official Title
UPLYFT For Lymphoma Survivors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of lymphoma (indolent non-Hodgkin lymphoma, aggressive non-Hodgkin lymphoma, or classic Hodgkin lymphoma)
- Age 218 years or older
- Completed first-line treatment between 3 months and 24 months ago
- Currently in complete remission after first-line treatment
- Clinically significant fear of cancer recurrence (score 216 on the FCR Inventory-Severity Subscale)
- Access to a computer for videoconferencing
- Lymphoma clinicians with at least 1 year since oncology fellowship completion or mental health clinicians with at least 1 year since clinical training
- Providing longitudinal clinical care for lymphoma patients or cancer patients (for clinicians)
You will not qualify if you...
- Age less than 18 years
- Concurrent other malignancy
- Uncontrolled or untreated psychotic disorders
- Untreated bipolar or borderline personality disorder
- Adults unable to consent
- Individuals younger than 18 years (infants, children, teenagers)
- Pregnant women
- Prisoners
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02215
Actively Recruiting
Research Team
O
Oreofe O Odejide, MD, MPH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here